|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Thalidomide for patients with recurrent|ymphoma显示文摘 | Barbear P Anas Y Maher A el al | 2004 | Cancer2004，100，： | 1 |
| 2 | Double-blind con- trolled trial of the Garren-Edwards gastric bubble: an adjunctive treatment for exogenous obesity 显示文摘 | Benjamin SB Maher KA Cattau EL | 1988 | Gastroenterology1988，95，3： | 1 |
| 3 | Assessment ofdysmenorrhea and menstrual hy-giene practices among adolescentgirls in some nursing schools atEL - Minia Governorate, Egypt显示文摘 | Neamat A Abd El - Hameed Maher S | 2011 | Journal of American-Science2011，7，9： | 1 |
| 4 | Double blind controlled trial of the Garren-Edward gastric bubble:an adjunctive treat- ment for exogenous obesity 显示文摘 | Benjamin SB Maher KA Cattau EL | 1988 | Gastroenterology1988，95，6： | 1 |
| 5 | Antioxidant activity and nutrient composition of Selected ce- reals for food use显示文摘 | Sanaa Ragaee El - Sayed M Abdel - Aal Maher Noaman | 2006 | Food Chemistry2006，98，： | 1 |
| 6 | The use of the hospital anxiety and depression scale (HADS) and the EORTC QLQ - C30 questionnaires to screen for treatment needs in patients attending routinely for radiotherapy显示文摘 | Maher El Mackenzie C Young T | 1996 | Cancer Treat Rev1996，22，： | 1 |
| 7 | A retrospective review of three antibiotic prophylaxis regimens for pediatric cardiac surgical patients显示文摘 | Maher KO Van Der Elzen K Bove EL | 2002 | Ann Thorac Surg2002，74，4： | 1 |
| 8 | Tile prognosis of acute and persistent hw-hak pain: a mela-amdysis 显示文摘 | Da C Menezs Csla L Maher C ltanock M J el al | 2012 | CMA J2012，184，11： | 1 |
| 9 | The effect of cardiopulmonary resuscitation training on psychological variables of cardiac rehabilitation patients 显示文摘 | Ingrain S Maher V Bennett K el al | 2006 | Resuscitation2006，71，1： | 1 |
| 10 | The growing burden of tuberculosis: global trends and interactions with the HIV epidemic显示文摘 | Corbett EL Watt C J Walker N Maher D Williams BG Raviglione MC Dye C | 2003 | Arch Intern Med2003，163，9： | 1 |
| 11 | Early results of chemo-immunotherapy regimen of fludarabine,cyclophospha-mide, and rituximab as initial therapy for chronic lymphocytic leukemia 显示文摘 | Michael JK Susan O'B Maher A el al | 2005 | J Clin Oncol2005，18，23： | 1 |
| 12 | Activali,m of poslsynaptic Ca (2+) stores modulales glulamate receptor cycling in hippocampal neurons显示文摘 | MAHER B J MACKINNON R 1 BAI 1 el al | 2005 | J Neurophysiol2005，93，1： | 1 |
| 13 | Significance of incidentalthyroid lesions detected on CT : Correlation among CT,sonogra-phy ,and pathology 显示文摘 | Shetty SK Maher MM Hahn PF el al | 2006 | American Journal of Roentgenology2006，187，5： | 1 |
| 14 | Improved LC methods for the determination of diosmin and/or hesperidin in plant extracts and pharmaceutical formulations显示文摘 | Azza M Shafae EL Maher M | 2001 | J Pharm Bio Ana2001，26，4： | 1 |
| 15 | A retrospective review three antibiotic prophylaxis regimens for pediatric cardiac surgical patients显示文摘 | Maher KO Van Der Elzen K Bove EL | 2002 | Ann Thorac Surg2002，74，4： | 1 |
| 16 | Spectrophotometric and chromatographic determination of rabeprazole in presence of its degradation products 显示文摘 | ElGindy A ElYazby F Maher MM | 2003 | Pharm Biomed Anal2003，31，2： | 1 |
| 17 | Hepatic and gastrointestinal disturbances in Egyptian patients infected with coronavirus disease 2019: A multicentre cohort study显示文摘BACKGROUND Various liver and gastrointestinal involvements occur in patients with coronavirus disease 2019(COVID-19)at variable prevalence.Most studies report mild liver function disturbances correlated with COVID-19 severity,though liver failure is unusual.AIM To study liver and gastrointestinal dysfunctions in Egyptian patients with COVID-19 and their relation to disease outcomes METHODS This multicentre cohort study was conducted on 547 Egyptian patients from April 15,2020 to July 29,2020.Consecutive polymerase chain reaction-confirmed COVID-19 cases were included from four quarantine hospitals affiliated to the Egyptian ministry of health.Demographic information,laboratory characteristics,treatments,fibrosis-4(FIB-4)index,COVID-19 severity,and outcomes were recorded and compared according to the degree of liver enzyme elevation and the presence of gastrointestinal symptoms.Follow-ups were conducted until discharge or death.Regression analyses were performed to determine the independent factors affecting mortality.RESULTS This study included 547 patients,of whom 53(9.68%)died during hospitalization and 1 was discharged upon his request.Patients’mean age was 45.04±17.61 years,and 21.98%had severe or critical COVID-19.Alanine aminotransferase(ALT)and aspartate aminotransferase(AST)were available for 430 and 428 patients,respectively.In total,26%and 32%of patients had elevated ALT and AST,respectively.Significant liver injury with ALT or AST elevation exceeding 3-fold was recorded in 21(4.91%)and 16(3.73%)patients,respectively.Male gender,smoking,hypertension,chronic hepatitis C,and lung involvement were associated with elevated AST or ALT.AST was elevated in 50%of patients over 60-years-old.FIB-4 was significantly higher in patients admitted to the intensive care unit(ICU),those with more severe COVID-19,and non-survivors.The independent variables affecting outcome were supplementary vitamin C intake(1 g daily capsules)[odds ratio(OR):0.05,95%confidence interval(CI):0.008–0.337];lung consolidation(OR:4.540,95%CI:1.155–17.840);ICU admission(OR:25.032,95%CI:7.110–88.128);and FIB-4 score>3.25(OR:10.393,95%CI:2.459-43.925).Among 60(13.98%)patients with gastrointestinal symptoms,52(86.67%)had diarrhoea.Patients with gastrointestinal symptoms were predominantly females with higher body mass index,and 50(83.40%)patients had non-severe COVID-19.CONCLUSION Few Egyptian patients with COVID-19 developed a significant liver injury.The independent variables affecting mortality were supplementary vitamin C intake,lung consolidation,ICU admission,and FIB-4 score. | Hend Ibrahim Shousha Shimaa Afify Rabab Maher Noha Asem Eman Fouad Ehab F Mostafa Mohammed A Medhat Amr Abdalazeem Hazem Elmorsy Miriam M Aziz Rateba S Mohammed Mohamed Ibrahem Hassan Elgarem Dalia Omran Mohamed Hassany Bassem Elsayed Ahmed Y Abdelaziz Mohamed El Kassas | 2021 | World Journal of Gastroenterology2021，27，40： | 1 |
| 18 | Phenolic content, antioxidant and allelopathic activities of various extracts of Thymus numidicus Poir. organs显示文摘 | Imen Ben El Hadj Ali Radhia Bahri Maher Chaouachi Mohamed Boussa?d Fethia Harzallah-Skhiri | 2014 | Industrial Crops & Products2014，，： | 1 |
| 19 | The growing burden of tubercuosis:global trends and imeractions with the HIV epidemic显示文摘 | Corbett EL Watt CJ Walker N Maher D Williams BG Rav-iglione MC Dye C | | 0，，： | 1 |
| 20 | The potency of N,N′-diphenyl-1,4-phenylenediamine and adiposederived stem cell co-administration in alleviating hepatorenal dysfunction complications associated with type 1 diabetes mellitus in rats显示文摘Background:The increasing occurrence of diabetes mellitus(DM)noted worldwide has considerably elicited concern in the recent past.DM is associated with elevated vascular complications,morbidity,mortality,and poor quality of life.In this context,mesenchymal stem cells(MSCs)have shown significant therapeutic potentialities in managing and curing type 1 DM owing to their self-renewable,immunosuppressive,and differentiation capacities.We investigated the potential action of N,N′-diphenyl-1,4-phenylenediamine(DPPD),a well-known synthetic antioxidant to enhance the therapeutic ability of the adipose-derived stem cells(AD-MSCs)in alleviating kidney and liver complications in diabetic rats.Methods:Over the four weeks of experiments,albino male rats(n=36)were split into six test groups:control,DPPD(250 mg/kg,i.p.),STZ-diabetic(D),D+DPPD,D+AD-MSCs(1×10^(6)cell/rat,i.v.),and D+AD-MSCs+DPPD treated groups.Results:Significant declines in the renal and hepatic oxidative stress markers(MDA,ROS,and AGEs)were observed coupled with a significant elevation in many antioxidant marker levels(GSH,SOD,CAT,GPx,HO-1,and TAC)in the diabetic rats treated with either DPPD or AD-MSCs or their co-administered injection compared to the diabetic untreated rats.This was suggested to be the leading cause of amelioration of the kidney functions(as measured by urea,uric acid,and creatine levels)and liver functions(as evidenced by the levels of AST,ALT,ALP,bilirubin,total proteins,albumin,and globulins).Conclusion:DPPD and AD-MSCs co-administration showed superior results in terms of the enhancement of the relative hepato-renal function,indicating the beneficial role of DPPD supplementation in increasing the therapeutic potential of AD-MSCs. | HANY M.ABD EL-LATEEF SAFA H.QAHL EMAN FAYAD SARAH A.ALTALHI IBRAHIM JAFRI EL SHAIMAA SHABANA MARWA K.DARWISH REHAB MAHER SAAD SHAABAN SHADY G.EL-SAWAH | 2023 | BIOCELL2023，47，8： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员